ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in ImmunoGen, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- −9 vs. Q4 2022
- Shares held
- 210.0M
- +6.17M (+3.0%) vs. Q4 2022
- Total value
- $806.0M
- −$204.8M (−20.3%) vs. Q4 2022
- New holders
- 21
- 62 more added
- Sold out
- 30
- 57 more reduced
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $269 |
| Q1 2026 | 1 | $269 |
| Q4 2025 | 1 | $269 |
| Q3 2025 | 1 | $269 |
| Q2 2025 | 1 | $269 |
| Q1 2025 | 1 | $269 |
| Q4 2024 | 1 | $269 |
| Q3 2024 | 1 | $269 |
| Q2 2024 | 1 | $31 |
| Q1 2024 | 3 | $27.8K |
| Q4 2023 | 327 | $7.54B |
| Q3 2023 | 276 | $3.91B |
| Q2 2023 | 266 | $4.24B |
| Q1 2023 | 191 | $806.0M |
| Q4 2022 | 204 | $1.01B |
| Q3 2022 | 222 | $942.2M |
| Q2 2022 | 216 | $882.4M |
| Q1 2022 | 217 | $925.0M |
| Q4 2021 | 236 | $1.41B |
| Q3 2021 | 217 | $1.00B |
| Q2 2021 | 214 | $1.19B |
| Q1 2021 | 217 | $1.48B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding ImmunoGen, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prosperity Wealth Management, Inc. | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −27,472−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −27,336−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −26,077−100.0% | Sold out |
| Acrisure Capital Management, LLC | 0 | $0 | 0.00% | −20,320−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −18,605−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −15,674−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −15,582−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,270−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −4,932−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,140−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −1,488−100.0% | Sold out |
| Roble, Belko & Company, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −631−100.0% | Sold out |
| Hall Laurie J Trustee | 0 | $0 | 0.00% | −430−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −297−100.0% | Sold out |
| Centerpoint Advisors, LLC | 0 | $0 | 0.00% | −242−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Tradewinds, LLC. | 0 | $0 | 0.00% | −16,843−100.0% | Sold out |
| HealthCor Management, L.P. | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| HealthInvest Partners AB | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |